861 F. Supp. 2d 1111
S.D. Cal.2012Background
- Alphatec Holdings, Inc. is a public spine-implant company; acquisition of Scient’x by Alphatec is central to the suit.
- Healthpoint Capital and Alphatec-affiliated directors allegedly orchestrated a sale of Scient’x to Alphatec to inflate Alphatec’s stock price.
- Alphatec announced a $220–$225 million 2010 revenue guidance and later reaffirmed it through Q1 2010; an April 16, 2010 public offering reduced Healthpoint’s stake from 55% to 38.1%.
- On August 5, 2010 Alphatec revised 2010 guidance downward due to integration delays and market conditions, triggering a large stock drop.
- Plaintiffs allege violations of the Securities Act §§11, 12(a)(2) and Exchange Act §§10(b), 20(a) on behalf of a class; Fresno County Employees’ Retirement Association was appointed lead plaintiff.
- Court grants motions to dismiss all claims with leave to amend.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether §§11 and 12(a)(2) claims sound in fraud require Rule 9(b) | Plaintiffs allege misrepresentations/omissions; claims sound in fraud. | Defendants argue lack of Rule 9(b) specificity; some claims not fraud-based. | Claims sounded in fraud; but Rule 9(b) applies only to fraud, other claims bifurcated. |
| Safe harbor applicability to forward-looking statements | Forward-looking statements should not be protected if misleading. | Safe harbor applies to forward-looking statements with proper cautionary language. | Safe harbor protects certain forward-looking statements (revenue guidance and offset by savings) in May 10, 2010 announcements. |
| Whether there were misrepresentations/omissions under Item 303 and other disclosures | Omissions of integration delays, distributor data, and channel stuffing were required disclosures. | Disclosures already existed (pricing pressures, integration issues) or allegedly insufficient to state claims. | Plaintiffs failed to plead omissions or misrepresentations with required specificity; no §11 or §12(a)(2) liability. |
| Whether alleged omissions support a §10(b)/Rule 10b-5 claim | Omissions and misleading statements violated Exchange Act; scienter alleged. | Statements are non-actionable puffery; insufficient scienter; safe harbor may apply for some statements. | Claims fail for lack of material misrepresentation/omission and lack of pleadings of scienter. |
| Whether Healthpoint was a “seller” under §12(a)(2) | Healthpoint issued/solicited securities via Prospectus and had financial interest in the offering. | Healthpoint not the direct or preparer of the Prospectus; Rule 159A not clearly applicable. | Healthpoint not a seller; §12(a)(2) claim against Healthpoint dismissed. |
Key Cases Cited
- Rubke v. Capitol Bancorp, Ltd., 551 F.3d 1156 (9th Cir. 2009) (fraud pleading standards; unified course of fraudulent conduct)
- In re Daou Sys., Inc. Sec. Litig., 411 F.3d 1006 (9th Cir. 2005) (Rule 9(b) and scienter standards in Exchange Act claims)
- In re Stac Elecs. Sec. Litig., 89 F.3d 1399 (9th Cir. 1996) (fraud pleading standards; incorporation of documents by reference)
- In re Copper Mountain Sec. Litig., 311 F.Supp.2d 857 (N.D. Cal. 2004) (forward-looking statements and non-forward-looking distinctions)
- In re Cutera Sec. Litig., 610 F.3d 1103 (9th Cir. 2010) (safe harbor for forward-looking statements; cautionary language sufficiency)
- Yourish v. Cal. Amplifier, 191 F.3d 993 (9th Cir. 1999) (fraud pleading; need for falsity and reason why statement misleading)